Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is an open-label, multicenter, Phase 2 study to evaluate the efficacy and safety of oral selinexor in participants with recurrent gliomas.
Epistemonikos ID: c4fe344bf623c727924d83493e1d5769112f2675
First added on: May 11, 2024